NGS enables broad detection of known and novel viruses in a single assay. Its high sensitivity, specificity, and scalability can meet GMP throughput levels.
- The Promise Of MRD-Guided CAR-T Treatment
- CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- A QMS That Anticipates Cell And Gene Therapy Quality Challenges
- Using Digital Platforms To Find Your CDMO
- July 2026 — CDMO Opportunities And Threats Report
- ADC CDMO Selection For Small Biotech
- Implementing AI Solutions In GMP While Managing Risk
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![cancer cell-tumor-GettyImages-1168181061]( "AI Unveils Tumor-Immune Landscape In Colorectal Adenocarcinoma")
AI Unveils Tumor-Immune Landscape In Colorectal AdenocarcinomaAI-powered multiplexed imaging and analysis explore the tumor-immune microenvironment in colorectal adenocarcinoma, identifying potential biomarkers for therapeutic insights.
-
![GettyImages-2166551611 ddPCR]( "Measuring AAV Vector Genome Titer Using Droplet Digital PCR Protocol")
Measuring AAV Vector Genome Titer Using Droplet Digital PCR ProtocolAchieve highly consistent and precise AAV vector genome titer measurements with this optimized ddPCR protocol. This method ensures accurate dosing and optimal cell therapy potency.
-
![GettyImages-1200984194 elderly mobility]( "Delivering Specialist Neurology Support")
Delivering Specialist Neurology SupportExplore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay")
384-Well Microplate Time Resolved Fluorescence (TRF) ImmunoassayExamine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.
-
![Improving Bioprocess Monitoring And Control With Multivariate Data Analysis]( "Improving Bioprocess Monitoring And Control With Multivariate Data Analysis")
Improving Bioprocess Monitoring And Control With Multivariate Data AnalysisLearn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.
-
![GettyImages-1346675635-laboratory-analysis-research-microscope]( "Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation")
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With AutomationGrowing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
-
![GettyImages-2183428964 lab]( "Analytical Method Release And Stability Platform For RNA Drug Substance")
Analytical Method Release And Stability Platform For RNA Drug SubstanceWe offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.
-
![mRNA-analysis-blue]( "High-Sensitivity IVT mRNA Analysis")
High-Sensitivity IVT mRNA AnalysisQuality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research.
-
![GettyImages-1356993441 mRNA]( "Automation And Digital Solutions Can Help You Reach Your mRNA Manufacturing And Sustainability Goals")
Automation And Digital Solutions Can Help You Reach Your mRNA Manufacturing And Sustainability GoalsExplore how digital solutions help streamline mRNA manufacturing by reducing costs, improving efficiency, and supporting sustainability by creating paperless processes for emerging therapeutics.
-
![Viral Safety In Monoclonal Antibody Manufacturing-Getty-184714532]( "Study Viral Infection In Resting Humans CD4+ T Cells With Synthetic sgRNAs")
Study Viral Infection In Resting Humans CD4+ T Cells With Synthetic sgRNAsDiscover how Synthego's proprietary synthetic sgRNA, combined with Lonza’s 4D-Nucleofector®, enabled highly efficient gene editing in resting human CD4+ T cells.
NEWSLETTER ARCHIVE
- 09.12.26 -- Cell & Gene Newsletter - Best Of August
- 09.11.26 -- Why Autoimmune CAR T Needs A New Patient-Centered Playbook — With Dr. Panteli Theocharous
- 09.10.26 -- Is Your Fill/Finish Strategy Ready To Scale?
- 09.10.26 -- In Vivo CAR T Needs More Than Better Cell Engineering
- 09.09.26 -- Smarter Ways To Reduce Risk, Downtime, And Lifecycle Surprises
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- Why Celcuity's REVTORPYK Creates A New Path For Precision Oncology
- In Vivo CAR T Needs More Than Better Cell Engineering
- Reimagining Solid Tumor Immunotherapy With SRC-3-Edited Tregs
- Building Antigen-Specific Immune Tolerance For Autoimmune Disease
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
